Hoefsloot, W
Dacheva, E
van der Laan, R
Krol, M
van Ingen, J
Obradovic, M
Liu, Ximeng
Funding for this research was provided by:
Insmed B.V.
Article History
Received: 24 November 2022
Accepted: 28 April 2023
First Online: 20 June 2023
Declarations
:
: At the time this research was finalized, Elena Dacheva was an employee of IQVIA Netherlands. Marieke Krol is a current employee of IQVIA Netherlands. Marko Obradovic and Roald van der Laan are current employees of Insmed B.V. The authors report no further conflicts of interest.
: All the research activities were performed in accordance with the declaration of Helsinki.This non-interventional study analyzing anonymous data will not include people, medical records, or human tissue, therefore this study does not fall into the scope of the Dutch Medical Research Involving Human Subjects Act (Wet medisch-wetenschappelijk onderzoek met mensen: WMO). Ethical approval is, consequently, not required in the Netherlands. The anonymization and use of the data will be conducted compliant with Dutch data privacy law (Wet bescherming persoonsgegevens: Wbp). IQVIA and Radboud UMC will follow all relevant local privacy requirements. Furthermore, the database used for the study has in-built anonymization processes, managed by a trusted third party. This guarantees that the raw data and final deliverables cannot be traced to an identifiable patient.
: Not applicable.